Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Elixie
Elixie Overview
Elixie is a clinical-stage biotech company enhancing cannabinoids for symptomatic relief of neurological disorders based on NANOLIX, a patented clinically proven Self-nano emulsifying drug delivery system (SNEDDS).
By encapsulating validated APIs in in-human-proven NANOLIX and targeting orphan diseases, Elixie will register pharmaceuticals in a relatively short route to market and with minimal risks.